OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

SWEDISH ORPHAN BIOVIT.SK1/  SE0000872095  /

Berlin
2024-08-09  8:08:15 AM Chg. +0.660 Volume Bid8:59:39 PM Ask8:59:39 PM Market Capitalization Dividend Y. P/E Ratio
23.920EUR +2.84% 0
Turnover: 0.000		 -Bid Size: - -Ask Size: - 8.6 bill.EUR - -
GlobeNewswire 05-24 Sobi to present new myelofibrosis data at the ASCO 2024 Annual Meeting
GlobeNewswire 05-24 Sobi Receives US FDA Fast Track Designation for Emapalumab-lzsg being investigated in Macrophage Act...
GlobeNewswire 2021-09-07 Nature Medicine publishes positive phase 3 anakinra study results in patients with COVID-19 pneumoni...
GlobeNewswire 2020-12-22 FDA Approves KINERET® (anakinra) for the Treatment of Deficiency of IL-1 Receptor Antagonist (DIRA)
GlobeNewswire 2016-05-04 Swedish Orphan Biovitrum AB (publ): Bo Jesper Hansen sells 8 million shares
GlobeNewswire 2016-04-29 Sobi signs manufacturing agreements with Pfizer
GlobeNewswire 2016-04-27 Sobi publishes its report for the first quarter 2016
GlobeNewswire 2016-04-27 Sobi publishes 2015 Annual Report
GlobeNewswire 2016-04-26 Orfadin® Oral Suspension approved in the US
GlobeNewswire 2016-04-22 Sobi signs licensing agreement with Affibody for IL-1
GlobeNewswire 2016-04-21 European patent granted on new formulation of Kineret® (anakinra)
GlobeNewswire 2016-04-20 Notice of annual general meeting in Swedish Orphan Biovitrum AB (publ)
GlobeNewswire 2016-04-11 COMP recommends that Alprolix® maintains orphan designation for treatment of haemophilia B
GlobeNewswire 2016-03-24 European Commission approves transfer of marketing authorisation for Elocta® to Sobi
GlobeNewswire 2016-03-08 Sobi announces new date for Annual General Meeting of shareholders
GlobeNewswire 2016-02-29 Sobi updates outlook for 2016
GlobeNewswire 2016-02-26 Sobi and Biogen receive positive opinion from CHMP for Alprolix® (rFIXFc) for the treatment of haemo...
GlobeNewswire 2016-02-26 Bo Jesper Hansen to step down as Chairman of Sobi - Håkan Björklund to be nominated as new Chairman ...
GlobeNewswire 2016-02-26 Sobi publishes its report for the fourth quarter and full year 2015
GlobeNewswire 2016-02-23 Sobi to initiate clinical development programs in acute gout and Still's disease, and receives US pa...
GlobeNewswire 2016-02-17 Invitation - Presentation of Sobi's fourth quarter and full year results 2015
GlobeNewswire 2016-01-28 Sobi to present new interim ASPIRE data at EAHAD congress suggesting that patients can reduce bleedi...
GlobeNewswire 2016-01-19 Sobi's Orfadin® oral suspension granted European patent
GlobeNewswire 2016-01-14 Chief Medical Officer Birgitte Volck to leave Sobi
GlobeNewswire 2016-01-11 Sobi(TM) announces commercial launch of Elocta® in first countries in Europe